Skip Navigation

Europace 2000 2(2):115-118; doi:10.1053/eupc.2000.0090
© 2000 by European Society of Cardiology
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Carlsson, J.
Right arrow Articles by Tebbe, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlsson, J.
Right arrow Articles by Tebbe, U.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Stroke prevention practices in patients with atrial fibrillation and pacemaker therapy

Evidence for under-use of anticoagulation

J. Carlsson1, S. Miketic2, G. Dees2, S. Haun2, A. Cuneo2 and U. Tebbe2

1Department of Cardiology, Kerckhoff-Klinik Bad Nauheim, Germany; 2Medizinische Klinik II, Klinikum Lippe-Detmold Detmold, Germany

This study presents a survey of pacemaker patients followed in a pacemaker clinic. Three hundred and twenty-six patients of mean age 77·7±9·6 years, 52% female, 75% VVI, 25% dual chamber were analysed. One hundred and forty (43%) were in atrial fibrillation and were older, 80·5±7·1 years, compared with 75·5±11·4 years (P=0·014) for those in sinus rhythm. Temporary pacemaker reprogramming was necessary in 86% in order to determine the abnormal rhythm. Thirty-nine (28%) of those in atrial fibrillation were anticoagulated; 37% were on aspirin; only 10·8% of those in atrial fibrillation who were not anticoagulated had contraindications to this therapy. Prevalence of atrial fibrillation increased with age, whereas that of anticoagulation decreased with age. In conclusion, the majority of pacemaker patients with atrial fibrillation, for whom anticoagulation is indicated, fails to receive it: those caring for these patients are urged to ensure its much wider use.

Key Words: Atrial fibrillation, pacemaker, oral anticoagulation

Correspondence: Joerg Carlsson, MD, Kerckhoff-Klinik, Dept. of Cardiology, Beneke-Strasse 2–8, D-61231 Bad Nauheim, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
L. Padeletti, M. Santini, G. Boriani, G. Botto, A. Capucci, M. Gulizia, R. Ricci, A. Spampinato, P. Pieragnoli, E. Warman, et al.
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients
Eur. Heart J., January 2, 2005; 26(2): 165 - 172.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.